SMI
13.625,55
PKT
+95,63
PKT
+0,71
%
Werbung
Analysen zu SMI-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 02.11.17 | Swiss Re Hold | Baader Bank | |
| 02.11.17 | Swiss Re Reduce | Commerzbank AG | |
| 01.11.17 | ABB (Asea Brown Boveri) Hold | Deutsche Bank AG | |
| 01.11.17 | Holcim Hold | Deutsche Bank AG | |
| 01.11.17 | Holcim Neutral | UBS AG | |
| 01.11.17 | Holcim Hold | HSBC | |
| 01.11.17 | ABB (Asea Brown Boveri) buy | Kepler Cheuvreux | |
| 31.10.17 | Swiss Re Sell | UBS AG | |
| 31.10.17 | Novartis Neutral | JP Morgan Chase & Co. | |
| 31.10.17 | ABB (Asea Brown Boveri) overweight | Barclays Capital | |
| 31.10.17 | Novartis buy | HSBC | |
| 31.10.17 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 31.10.17 | Swiss Re Neutral | Goldman Sachs Group Inc. | |
| 31.10.17 | ABB (Asea Brown Boveri) Conviction Buy | Goldman Sachs Group Inc. | |
| 30.10.17 | UBS Hold | Société Générale Group S.A. (SG) | |
| 30.10.17 | UBS Sector Perform | RBC Capital Markets | |
| 30.10.17 | Holcim Underweight | Barclays Capital | |
| 30.10.17 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 30.10.17 | Holcim buy | Citigroup Corp. | |
| 30.10.17 | UBS overweight | JP Morgan Chase & Co. | |
| 30.10.17 | Novartis buy | Baader Bank | |
| 30.10.17 | UBS Neutral | Goldman Sachs Group Inc. | |
| 30.10.17 | Novartis Neutral | UBS AG | |
| 30.10.17 | Holcim Hold | Deutsche Bank AG | |
| 30.10.17 | Holcim Hold | Kepler Cheuvreux | |
| 30.10.17 | Novartis buy | HSBC | |
| 30.10.17 | Novartis Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 27.10.17 | Holcim buy | S&P Capital IQ | |
| 27.10.17 | UBS Neutral | Credit Suisse Group | |
| 27.10.17 | Richemont Hold | Société Générale Group S.A. (SG) | |
| 27.10.17 | ABB (Asea Brown Boveri) Equal-Weight | Morgan Stanley | |
| 27.10.17 | UBS overweight | JP Morgan Chase & Co. | |
| 27.10.17 | ABB (Asea Brown Boveri) Hold | Société Générale Group S.A. (SG) | |
| 27.10.17 | ABB (Asea Brown Boveri) Neutral | Goldman Sachs Group Inc. | |
| 27.10.17 | ABB (Asea Brown Boveri) overweight | Barclays Capital | |
| 27.10.17 | Zurich Insurance buy | Citigroup Corp. | |
| 27.10.17 | Holcim Outperform | Bernstein Research | |
| 27.10.17 | Swiss Re Neutral | Credit Suisse Group | |
| 27.10.17 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 26.10.17 | UBS buy | UBS AG |
* Die angezeigten Realtime Kurse sind indikativ und nicht die offiziellen Börsenkurse. Die Kursdaten können eventuell vom tatsächlichen Marktpreis abweichen.